Elyxium Wealth’s Ionis Pharmaceuticals IONS Stock Holding History

Elyxium Wealth’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.14K	Buy	+48	New	+$2.73K	﹤0.01%	1302

Other funds holding IONS

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Motley Fool Asset Management Alexandria, Virginia $2.64B AUM 26.58% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return

Elyxium Wealth's IONS Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 48 shares worth $2.14K. The stake represents ﹤0.01% of the portfolio and ranks #1302 among its holdings.

90 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

Elyxium Wealth held 48 shares of Ionis Pharmaceuticals worth $2.14K as of Q3 2026.
Ionis Pharmaceuticals was a new Elyxium Wealth position in Q3 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1302 holding.
90 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.